acitretin has been researched along with Eye Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, KB; McClure, SL; Valentine, J | 1 |
| Katz, HI; Leach, EE; Waalen, J | 1 |
| Halioua, B; Saurat, JH | 1 |
3 review(s) available for acitretin and Eye Diseases
| Article | Year |
|---|---|
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
Acitretin in psoriasis: an overview of adverse effects.
Topics: Abnormalities, Drug-Induced; Acitretin; Drug Interactions; Etretinate; Eye Diseases; Female; Humans; Hyperlipidemias; Hyperostosis; Keratolytic Agents; Liver; Male; Mucous Membrane; Pancreatitis; Pseudotumor Cerebri; Skin Diseases | 1999 |
Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Aged; Bone Diseases; Chemical and Drug Induced Liver Injury; Etretinate; Eye Diseases; Female; Humans; Lipids; Male; Middle Aged; Psoriasis; Risk Factors; Skin Diseases; Tretinoin | 1990 |